Notably, in vivo studies suggest that amoxicillin inhibits the upregulation of transforming growth factor-β (TGF-β) [30], a cytokine implicated in AD pathology including Aβ accumulation [36], microglial activation [37], and neurodegeneration [143]. The gene discussed is TGFB1; the disease is Alzheimer disease.